+Follow
Jasonteo
No personal profile
138
Follow
1
Followers
0
Topic
0
Badge
Posts
Hot
Jasonteo
2021-08-01
Good
Sorry, the original content has been removed
Jasonteo
2021-07-20
??
Sorry, the original content has been removed
Jasonteo
2021-07-13
Good
Opening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.
Jasonteo
2021-07-12
Nice
Sorry, the original content has been removed
Jasonteo
2021-07-12
Excited
Tengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.
Jasonteo
2021-07-12
Excited
Sorry, the original content has been removed
Jasonteo
2021-06-29
Good
The Most Epic Back-to-School Season Ever: 2 Stocks to Watch
Jasonteo
2021-06-28
Good
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3586549737202999","uuid":"3586549737202999","gmtCreate":1623455910792,"gmtModify":1626058703601,"name":"Jasonteo","pinyin":"jasonteo","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":138,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":802614170,"gmtCreate":1627776593790,"gmtModify":1703495591619,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/802614170","repostId":"1165085669","repostType":4,"isVote":1,"tweetType":1,"viewCount":5811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171283674,"gmtCreate":1626746246698,"gmtModify":1703764336165,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171283674","repostId":"2152955658","repostType":4,"isVote":1,"tweetType":1,"viewCount":4755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142818216,"gmtCreate":1626140518635,"gmtModify":1703754112950,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142818216","repostId":"1199045893","repostType":4,"repost":{"id":"1199045893","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626139221,"share":"https://ttm.financial/m/news/1199045893?lang=en_US&edition=fundamental","pubTime":"2021-07-13 09:20","market":"hk","language":"zh","title":"Opening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.","url":"https://stock-news.laohu8.com/highlight/detail?id=1199045893","media":"老虎资讯综合","summary":"7月13日,恒生指数开盘上涨178.79点,涨幅0.65%,报27694.03点;国企指数开盘上涨49.98点,涨幅0.5%,报9995.71点;红筹指数开盘上涨18.1点,涨幅0.47%,报3867","content":"<p>On July 13, the Hang Seng Index opened up 178.79 points, or 0.65%, at 27,694.03. The state-owned enterprises index opened 49.98 points higher, or 0.5%, at 9995.71. The red-chip index opened 18.1 points higher, or 0.47%, at 3867.61.</p><p>The Hang Seng Tech Index rose 0.54%, with major tech stocks rebounding.<a href=\"https://laohu8.com/S/00700\">Tencent Holdings</a>、<a href=\"https://laohu8.com/S/BABA\">Alibaba</a>、<a href=\"https://laohu8.com/S/09888\">Baidu Group - SW</a>、<a href=\"https://laohu8.com/S/09618\">JD.com - SW</a>Both rose by more than 1%;</p><p>Hong Kong-listed mobile game stocks led the gains.<a href=\"https://laohu8.com/S/02660\">Zenyou Technology</a>Up 3.36%<a href=\"https://laohu8.com/S/09999\">NetEase-S</a>Up 2.13%<a href=\"https://laohu8.com/S/00302\">CMGE</a>Up 0.52%;</p><p>New Shares<a href=\"https://laohu8.com/S/06913\">South China Vocational Education</a>On its first day of trading, the stock price fell below its issue price, opening down 8.8% at HK$1.59 per share.</p><p>New Shares<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>On its first day of trading, the stock price fell below its issue price, opening nearly 4% lower at HK$22.25 per share.</p><p><a href=\"https://laohu8.com/S/01799\">Xinte Energy</a>The company opened 5.75% higher and expects a profit attributable to owners of no less than RMB 1.15 billion in the first half of the year;</p><p><a href=\"https://laohu8.com/S/09969\">Innovent Biologics-B</a>The stock opened more than 4% higher, reaching a new high. Bojian reached a licensing and cooperation agreement with Bojian for orlabrutinib.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-13 09:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On July 13, the Hang Seng Index opened up 178.79 points, or 0.65%, at 27,694.03. The state-owned enterprises index opened 49.98 points higher, or 0.5%, at 9995.71. The red-chip index opened 18.1 points higher, or 0.47%, at 3867.61.</p><p>The Hang Seng Tech Index rose 0.54%, with major tech stocks rebounding.<a href=\"https://laohu8.com/S/00700\">Tencent Holdings</a>、<a href=\"https://laohu8.com/S/BABA\">Alibaba</a>、<a href=\"https://laohu8.com/S/09888\">Baidu Group - SW</a>、<a href=\"https://laohu8.com/S/09618\">JD.com - SW</a>Both rose by more than 1%;</p><p>Hong Kong-listed mobile game stocks led the gains.<a href=\"https://laohu8.com/S/02660\">Zenyou Technology</a>Up 3.36%<a href=\"https://laohu8.com/S/09999\">NetEase-S</a>Up 2.13%<a href=\"https://laohu8.com/S/00302\">CMGE</a>Up 0.52%;</p><p>New Shares<a href=\"https://laohu8.com/S/06913\">South China Vocational Education</a>On its first day of trading, the stock price fell below its issue price, opening down 8.8% at HK$1.59 per share.</p><p>New Shares<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>On its first day of trading, the stock price fell below its issue price, opening nearly 4% lower at HK$22.25 per share.</p><p><a href=\"https://laohu8.com/S/01799\">Xinte Energy</a>The company opened 5.75% higher and expects a profit attributable to owners of no less than RMB 1.15 billion in the first half of the year;</p><p><a href=\"https://laohu8.com/S/09969\">Innovent Biologics-B</a>The stock opened more than 4% higher, reaching a new high. Bojian reached a licensing and cooperation agreement with Bojian for orlabrutinib.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","relate_stocks":{"513600":"恒生指数ETF南方","02833":"恒指ETF","HSI":"恒生指数","HSCCI":"红筹指数","HSTECH":"恒生科技指数","HSCEI":"国企指数"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199045893","content_text":"7月13日,恒生指数开盘上涨178.79点,涨幅0.65%,报27694.03点;国企指数开盘上涨49.98点,涨幅0.5%,报9995.71点;红筹指数开盘上涨18.1点,涨幅0.47%,报3867.61点。\n恒生科技指数涨0.54%,大型科技股反弹,腾讯控股、阿里巴巴、百度集团-SW、京东集团-SW均涨逾1%;\n港股手游股涨幅居前,禅游科技涨3.36%,网易-S涨2.13%,中手游涨0.52%;\n新股华南职业教育上市首日破发,开跌8.8%,发行价为1.59港元/股;\n新股腾盛博药-B上市首日破发,开跌近4%,发行价22.25港元/股;\n新特能源高开5.75% 预期上半年拥有人应占利润不少于11.5亿元;\n诺诚健华-B高开超4%创新高 与渤健就奥布替尼达成许可及合作协议。","news_type":1,"symbols_score_info":{"513600":0.9,"MCHmain":0.9,"02833":0.9,"HSI":0.9,"MHImain":0.9,"HSCCI":0.9,"HHImain":0.9,"HSCEI":0.9,"HSImain":0.9,"HSTECH":0.9}},"isVote":1,"tweetType":1,"viewCount":4459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146119600,"gmtCreate":1626058265900,"gmtModify":1703752525155,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146119600","repostId":"2150309877","repostType":4,"isVote":1,"tweetType":1,"viewCount":4959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146194630,"gmtCreate":1626057548420,"gmtModify":1703752507975,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Excited ","listText":"Excited ","text":"Excited","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146194630","repostId":"1128521631","repostType":4,"repost":{"id":"1128521631","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626047703,"share":"https://ttm.financial/m/news/1128521631?lang=en_US&edition=fundamental","pubTime":"2021-07-12 07:55","market":"hk","language":"zh","title":"Tengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.","url":"https://stock-news.laohu8.com/highlight/detail?id=1128521631","media":"老虎资讯综合","summary":"7月12日,腾盛博药-B发布公告,发售价厘定为每股发售股份22.25港元,全球发售所得款项净额预计约为23.34亿港元(假设超额配股权未获行使),预期股份将于2021年7月13日(星期二)上午九时正(","content":"<p>On July 12,<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>The announcement stated that the offer price was set at HK$22.25 per offer share, and the net proceeds from the global offering are expected to be approximately HK$2.334 billion (assuming the over-allotment option is not exercised). Trading in the shares on the Stock Exchange is expected to commence at 9:00 a.m. (Hong Kong time) on Tuesday, July 13, 2021.</p><p><b>The relevant data compiled by Tiger Information is as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6804fe5ca9085f6481244e4a826c03d7\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Allocation Results:</b></p><p>Group A has 500 shares per lot, with a 5% success rate per lot. Subscribing to 40 lots guarantees one lot.</p><p>Group B had 30,000 shares (600 lots) and was allocated 4,500 shares (9 lots).</p><p><img src=\"https://static.tigerbbs.com/6cc9c803bdb4af0ada0033deaba2cc37\" tg-width=\"726\" tg-height=\"769\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/8be19769443a8c996cbf0f219b3cd790\" tg-width=\"734\" tg-height=\"392\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/6f25a813ef2012066cd493f9512952f7\" tg-width=\"738\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p><p>If the over-allotment option is exercised in full, the company will receive additional net proceeds of approximately HK$357 million for the 16.737 million additional offer shares to be issued upon the exercise of the over-allotment option.</p><p>The Hong Kong Public Offering was significantly oversubscribed. A total of 246,500 valid applications were received for a total of 3.259 billion Hong Kong Offer Shares, which is approximately 292 times the total number of 11.158 million Hong Kong Offer Shares initially available for subscription under the Hong Kong Public Offering.</p><p>As the Hong Kong Public Offering was oversubscribed by more than 100 times, 44.632 million offer shares were reallocated from the international offering to the Hong Kong Public Offering. The final number of offer shares under the Hong Kong Public Offering has thus increased to 55.79 million offer shares, representing 50% of the total number of offer shares initially available for subscription under the Global Offering (before any over-allotment option is exercised).</p><p>The Offer Shares initially offered under the International Offering have been significantly oversubscribed, representing approximately 12 times the total number of Offer Shares initially available under the International Offering. Following the reallocation of Offer Shares from the International Offering to the Hong Kong Public Offering, the final number of Offer Shares under the International Offering will be 55.79 million, representing 50% of the total number of Offer Shares initially available for subscription under the Global Offering (before the exercise of any Over-allotment Option). The international offering was over-allocated by 16.737 million shares, with a total of 160 placees.</p><p>Based on the Offer Price of HK$22.25 per Offer Share, the Cornerstone Investors have subscribed for a total of 53,027,500 Offer Shares pursuant to the Cornerstone Investment Agreement, representing approximately 7.51% of the Company's issued share capital immediately following the completion of the Global Offering and 47.52% of the number of Offer Shares under the Global Offering, both assuming that the Over-allotment Option is not exercised.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-12 07:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On July 12,<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>The announcement stated that the offer price was set at HK$22.25 per offer share, and the net proceeds from the global offering are expected to be approximately HK$2.334 billion (assuming the over-allotment option is not exercised). Trading in the shares on the Stock Exchange is expected to commence at 9:00 a.m. (Hong Kong time) on Tuesday, July 13, 2021.</p><p><b>The relevant data compiled by Tiger Information is as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6804fe5ca9085f6481244e4a826c03d7\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Allocation Results:</b></p><p>Group A has 500 shares per lot, with a 5% success rate per lot. Subscribing to 40 lots guarantees one lot.</p><p>Group B had 30,000 shares (600 lots) and was allocated 4,500 shares (9 lots).</p><p><img src=\"https://static.tigerbbs.com/6cc9c803bdb4af0ada0033deaba2cc37\" tg-width=\"726\" tg-height=\"769\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/8be19769443a8c996cbf0f219b3cd790\" tg-width=\"734\" tg-height=\"392\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/6f25a813ef2012066cd493f9512952f7\" tg-width=\"738\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p><p>If the over-allotment option is exercised in full, the company will receive additional net proceeds of approximately HK$357 million for the 16.737 million additional offer shares to be issued upon the exercise of the over-allotment option.</p><p>The Hong Kong Public Offering was significantly oversubscribed. A total of 246,500 valid applications were received for a total of 3.259 billion Hong Kong Offer Shares, which is approximately 292 times the total number of 11.158 million Hong Kong Offer Shares initially available for subscription under the Hong Kong Public Offering.</p><p>As the Hong Kong Public Offering was oversubscribed by more than 100 times, 44.632 million offer shares were reallocated from the international offering to the Hong Kong Public Offering. The final number of offer shares under the Hong Kong Public Offering has thus increased to 55.79 million offer shares, representing 50% of the total number of offer shares initially available for subscription under the Global Offering (before any over-allotment option is exercised).</p><p>The Offer Shares initially offered under the International Offering have been significantly oversubscribed, representing approximately 12 times the total number of Offer Shares initially available under the International Offering. Following the reallocation of Offer Shares from the International Offering to the Hong Kong Public Offering, the final number of Offer Shares under the International Offering will be 55.79 million, representing 50% of the total number of Offer Shares initially available for subscription under the Global Offering (before the exercise of any Over-allotment Option). The international offering was over-allocated by 16.737 million shares, with a total of 160 placees.</p><p>Based on the Offer Price of HK$22.25 per Offer Share, the Cornerstone Investors have subscribed for a total of 53,027,500 Offer Shares pursuant to the Cornerstone Investment Agreement, representing approximately 7.51% of the Company's issued share capital immediately following the completion of the Global Offering and 47.52% of the number of Offer Shares under the Global Offering, both assuming that the Over-allotment Option is not exercised.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","relate_stocks":{"02137":"腾盛博药-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128521631","content_text":"7月12日,腾盛博药-B发布公告,发售价厘定为每股发售股份22.25港元,全球发售所得款项净额预计约为23.34亿港元(假设超额配股权未获行使),预期股份将于2021年7月13日(星期二)上午九时正(香港时间)开始在联交所买卖。\n老虎资讯整理相关数据如下:\n\n分配结果:\n甲组每手500股,一手中签率5%,认购40手稳中一手。\n乙组头为3万股(600手),获配4500股(9手)。\n\n倘超额配股权获悉数行使,公司将就超额配股权获行使后拟发行的1673.7万股额外发售股份收取额外所得款项净额约3.57亿港元。\n香港公开发售获大量超额认购。合共接获24.65万份有效申请,认购合共32.59亿股香港发售股份,相当于香港公开发售项下初步可供认购香港发售股份总数1115.8万股的约292倍。\n由于香港公开发售的超额认购超过100倍,4463.2万股发售股份已由国际发售重新分配至香港公开发售。香港公开发售项下发售股份的最终数目由此增加至5579万股发售股份,相当于全球发售项下初步可供认购发售股份总数的50%(于任何超额配股权获行使前)。\n国际发售项下初步提呈发售的发售股份已获大幅超额认购,相当于国际发售项下初步可供认购发售股份总数的约12倍。于将发售股份由国际发售重新分配至香港公开发售后,国际发售项下发售股份最终数目为5579万股,相当于全球发售项下初步可供认购发售股份总数的50%(于任何超额配股权获行使前)。国际发售项下超额分配1673.7万股发售股份,并共有160名承配人。\n基于发售价每股发售股份22.25港元,根据基石投资协议,基石投资者已认购合共5302.75万股发售股份,相当于紧随全球发售完成后本公司已发行股本的约7.51%及全球发售项下发售股份数目的47.52%,两种情况均假设超额配股权未获行使。","news_type":1,"symbols_score_info":{"02137":0.9}},"isVote":1,"tweetType":1,"viewCount":5147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146196580,"gmtCreate":1626057341740,"gmtModify":1703752503199,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Excited ","listText":"Excited ","text":"Excited","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146196580","repostId":"2150583935","repostType":4,"isVote":1,"tweetType":1,"viewCount":5093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159861167,"gmtCreate":1624956261359,"gmtModify":1703848780751,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159861167","repostId":"1176326573","repostType":4,"repost":{"id":"1176326573","kind":"news","pubTimestamp":1624955903,"share":"https://ttm.financial/m/news/1176326573?lang=en_US&edition=fundamental","pubTime":"2021-06-29 16:38","market":"us","language":"en","title":"The Most Epic Back-to-School Season Ever: 2 Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=1176326573","media":"Motley Fool","summary":"Spending usually increases with back-to-school shopping. That effect could be magnified this year.","content":"<p>The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.</p>\n<p>The coronavirus pandemic forced an abrupt shift to online instruction for students of all ages. The return has been more gradual, as some states and countries have already brought students back to in-person learning. Still, the fall semester of school will see the biggest group yet returning from remote instruction.</p>\n<p>Two companies that are in a position to benefit from students returning to school are <b>Target</b>(NYSE:TGT) and <b>Chegg</b>(NYSE:CHGG). Let's take a closer look at why investors should keep an eye on these two stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2446f442d6523793c8a0dc8b18bda9c\" tg-width=\"700\" tg-height=\"466\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Target</b></p>\n<p>A return to in-person learning can create the need for students to buy school supplies, clothes, and electronics, all of which can be found in one trip to Target. My son started the pandemic in kindergarten, and when he goes back to school in August, he will be a second-grader. He will need new clothes, new shoes, and other school supplies.</p>\n<p>Surely, that will be the case for millions of students worldwide. What's different for this year is the especially longer time it has been since kids were last in school. In a typical back-to-school season, sales are brisk, even though students were out of school for a few months through summer. This time around, kids haven't been in school for over a year, so sales could be even greater. Investors should keep an eye on how that plays out.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d614dbcb6f3f07da000561aa012342fb\" tg-width=\"700\" tg-height=\"466\"><span>COLLEGE ENROLLMENT FELL BY 603,000 STUDENTS IN SPRING 2021. IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>2. Chegg</b></p>\n<p>Chegg, the online student learning aid, experienced a surge in demand during the pandemic. The company serves mostly college and high school students, and when instruction moved online, students were missing the vital interaction with instructors and teachers. Still, subscriber growth was robust even in the years before the pandemic. Studentsfind its services helpfuland a relative bargain at less than $20 per month.</p>\n<p>The pandemic wasn't all positive for Chegg's business. Many college students with the choice of going through remote instruction or taking time off chose the latter. Indeed, college enrollment fell by 603,000 students in the spring semester of 2021, the biggest decline in a decade. Further, many students who chose to attend college instead of taking a semester off registered for fewer classes than they normally would.</p>\n<p>With nearly all colleges offering in-person instruction in the fall semester, enrollment will likely increase; students are also likely to take more classes to make up for the lost time. That means more potentialstudents that could benefitfrom Chegg's services.</p>\n<p><b>Investor takeaway</b></p>\n<p>The back-to-school surge in spending at Target and Chegg could be an extension of a COVID-induced increase in revenue. As economies reopened, there was a worry amonginvestorsof a snapback of spending at businesses like Target and Chegg that benefited during the pandemic. The thesis has not played out, and it could be giving credence to the counterargument that habits formed during the pandemic are going to stick around long term. Target and Chegg are certainly working at helping consumers maintain those habits and stick with them.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Most Epic Back-to-School Season Ever: 2 Stocks to Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Most Epic Back-to-School Season Ever: 2 Stocks to Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:38 GMT+8 <a href=https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","CHGG":"Chegg Inc"},"source_url":"https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176326573","content_text":"The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.\nThe coronavirus pandemic forced an abrupt shift to online instruction for students of all ages. The return has been more gradual, as some states and countries have already brought students back to in-person learning. Still, the fall semester of school will see the biggest group yet returning from remote instruction.\nTwo companies that are in a position to benefit from students returning to school are Target(NYSE:TGT) and Chegg(NYSE:CHGG). Let's take a closer look at why investors should keep an eye on these two stocks.\nIMAGE SOURCE: GETTY IMAGES.\n1. Target\nA return to in-person learning can create the need for students to buy school supplies, clothes, and electronics, all of which can be found in one trip to Target. My son started the pandemic in kindergarten, and when he goes back to school in August, he will be a second-grader. He will need new clothes, new shoes, and other school supplies.\nSurely, that will be the case for millions of students worldwide. What's different for this year is the especially longer time it has been since kids were last in school. In a typical back-to-school season, sales are brisk, even though students were out of school for a few months through summer. This time around, kids haven't been in school for over a year, so sales could be even greater. Investors should keep an eye on how that plays out.\nCOLLEGE ENROLLMENT FELL BY 603,000 STUDENTS IN SPRING 2021. IMAGE SOURCE: GETTY IMAGES.\n2. Chegg\nChegg, the online student learning aid, experienced a surge in demand during the pandemic. The company serves mostly college and high school students, and when instruction moved online, students were missing the vital interaction with instructors and teachers. Still, subscriber growth was robust even in the years before the pandemic. Studentsfind its services helpfuland a relative bargain at less than $20 per month.\nThe pandemic wasn't all positive for Chegg's business. Many college students with the choice of going through remote instruction or taking time off chose the latter. Indeed, college enrollment fell by 603,000 students in the spring semester of 2021, the biggest decline in a decade. Further, many students who chose to attend college instead of taking a semester off registered for fewer classes than they normally would.\nWith nearly all colleges offering in-person instruction in the fall semester, enrollment will likely increase; students are also likely to take more classes to make up for the lost time. That means more potentialstudents that could benefitfrom Chegg's services.\nInvestor takeaway\nThe back-to-school surge in spending at Target and Chegg could be an extension of a COVID-induced increase in revenue. As economies reopened, there was a worry amonginvestorsof a snapback of spending at businesses like Target and Chegg that benefited during the pandemic. The thesis has not played out, and it could be giving credence to the counterargument that habits formed during the pandemic are going to stick around long term. Target and Chegg are certainly working at helping consumers maintain those habits and stick with them.","news_type":1,"symbols_score_info":{"CHGG":0.9,"TGT":0.9}},"isVote":1,"tweetType":1,"viewCount":5197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127853167,"gmtCreate":1624843997359,"gmtModify":1703845944961,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586549737202999","idStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127853167","repostId":"2146007781","repostType":4,"isVote":1,"tweetType":1,"viewCount":4514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":802614170,"gmtCreate":1627776593790,"gmtModify":1703495591619,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/802614170","repostId":"1165085669","repostType":4,"isVote":1,"tweetType":1,"viewCount":5811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159861167,"gmtCreate":1624956261359,"gmtModify":1703848780751,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159861167","repostId":"1176326573","repostType":4,"repost":{"id":"1176326573","kind":"news","pubTimestamp":1624955903,"share":"https://ttm.financial/m/news/1176326573?lang=en_US&edition=fundamental","pubTime":"2021-06-29 16:38","market":"us","language":"en","title":"The Most Epic Back-to-School Season Ever: 2 Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=1176326573","media":"Motley Fool","summary":"Spending usually increases with back-to-school shopping. That effect could be magnified this year.","content":"<p>The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.</p>\n<p>The coronavirus pandemic forced an abrupt shift to online instruction for students of all ages. The return has been more gradual, as some states and countries have already brought students back to in-person learning. Still, the fall semester of school will see the biggest group yet returning from remote instruction.</p>\n<p>Two companies that are in a position to benefit from students returning to school are <b>Target</b>(NYSE:TGT) and <b>Chegg</b>(NYSE:CHGG). Let's take a closer look at why investors should keep an eye on these two stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2446f442d6523793c8a0dc8b18bda9c\" tg-width=\"700\" tg-height=\"466\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Target</b></p>\n<p>A return to in-person learning can create the need for students to buy school supplies, clothes, and electronics, all of which can be found in one trip to Target. My son started the pandemic in kindergarten, and when he goes back to school in August, he will be a second-grader. He will need new clothes, new shoes, and other school supplies.</p>\n<p>Surely, that will be the case for millions of students worldwide. What's different for this year is the especially longer time it has been since kids were last in school. In a typical back-to-school season, sales are brisk, even though students were out of school for a few months through summer. This time around, kids haven't been in school for over a year, so sales could be even greater. Investors should keep an eye on how that plays out.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d614dbcb6f3f07da000561aa012342fb\" tg-width=\"700\" tg-height=\"466\"><span>COLLEGE ENROLLMENT FELL BY 603,000 STUDENTS IN SPRING 2021. IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>2. Chegg</b></p>\n<p>Chegg, the online student learning aid, experienced a surge in demand during the pandemic. The company serves mostly college and high school students, and when instruction moved online, students were missing the vital interaction with instructors and teachers. Still, subscriber growth was robust even in the years before the pandemic. Studentsfind its services helpfuland a relative bargain at less than $20 per month.</p>\n<p>The pandemic wasn't all positive for Chegg's business. Many college students with the choice of going through remote instruction or taking time off chose the latter. Indeed, college enrollment fell by 603,000 students in the spring semester of 2021, the biggest decline in a decade. Further, many students who chose to attend college instead of taking a semester off registered for fewer classes than they normally would.</p>\n<p>With nearly all colleges offering in-person instruction in the fall semester, enrollment will likely increase; students are also likely to take more classes to make up for the lost time. That means more potentialstudents that could benefitfrom Chegg's services.</p>\n<p><b>Investor takeaway</b></p>\n<p>The back-to-school surge in spending at Target and Chegg could be an extension of a COVID-induced increase in revenue. As economies reopened, there was a worry amonginvestorsof a snapback of spending at businesses like Target and Chegg that benefited during the pandemic. The thesis has not played out, and it could be giving credence to the counterargument that habits formed during the pandemic are going to stick around long term. Target and Chegg are certainly working at helping consumers maintain those habits and stick with them.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Most Epic Back-to-School Season Ever: 2 Stocks to Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Most Epic Back-to-School Season Ever: 2 Stocks to Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 16:38 GMT+8 <a href=https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","CHGG":"Chegg Inc"},"source_url":"https://www.fool.com/investing/2021/06/28/back-to-school-season-stocks-watch-target-chegg/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176326573","content_text":"The 2021 back-to-school shopping season could be the most epic ever. Millions of students worldwide will be preparing to return to in-person learning for the first time since March 2020.\nThe coronavirus pandemic forced an abrupt shift to online instruction for students of all ages. The return has been more gradual, as some states and countries have already brought students back to in-person learning. Still, the fall semester of school will see the biggest group yet returning from remote instruction.\nTwo companies that are in a position to benefit from students returning to school are Target(NYSE:TGT) and Chegg(NYSE:CHGG). Let's take a closer look at why investors should keep an eye on these two stocks.\nIMAGE SOURCE: GETTY IMAGES.\n1. Target\nA return to in-person learning can create the need for students to buy school supplies, clothes, and electronics, all of which can be found in one trip to Target. My son started the pandemic in kindergarten, and when he goes back to school in August, he will be a second-grader. He will need new clothes, new shoes, and other school supplies.\nSurely, that will be the case for millions of students worldwide. What's different for this year is the especially longer time it has been since kids were last in school. In a typical back-to-school season, sales are brisk, even though students were out of school for a few months through summer. This time around, kids haven't been in school for over a year, so sales could be even greater. Investors should keep an eye on how that plays out.\nCOLLEGE ENROLLMENT FELL BY 603,000 STUDENTS IN SPRING 2021. IMAGE SOURCE: GETTY IMAGES.\n2. Chegg\nChegg, the online student learning aid, experienced a surge in demand during the pandemic. The company serves mostly college and high school students, and when instruction moved online, students were missing the vital interaction with instructors and teachers. Still, subscriber growth was robust even in the years before the pandemic. Studentsfind its services helpfuland a relative bargain at less than $20 per month.\nThe pandemic wasn't all positive for Chegg's business. Many college students with the choice of going through remote instruction or taking time off chose the latter. Indeed, college enrollment fell by 603,000 students in the spring semester of 2021, the biggest decline in a decade. Further, many students who chose to attend college instead of taking a semester off registered for fewer classes than they normally would.\nWith nearly all colleges offering in-person instruction in the fall semester, enrollment will likely increase; students are also likely to take more classes to make up for the lost time. That means more potentialstudents that could benefitfrom Chegg's services.\nInvestor takeaway\nThe back-to-school surge in spending at Target and Chegg could be an extension of a COVID-induced increase in revenue. As economies reopened, there was a worry amonginvestorsof a snapback of spending at businesses like Target and Chegg that benefited during the pandemic. The thesis has not played out, and it could be giving credence to the counterargument that habits formed during the pandemic are going to stick around long term. Target and Chegg are certainly working at helping consumers maintain those habits and stick with them.","news_type":1,"symbols_score_info":{"CHGG":0.9,"TGT":0.9}},"isVote":1,"tweetType":1,"viewCount":5197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146194630,"gmtCreate":1626057548420,"gmtModify":1703752507975,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Excited ","listText":"Excited ","text":"Excited","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146194630","repostId":"1128521631","repostType":4,"repost":{"id":"1128521631","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626047703,"share":"https://ttm.financial/m/news/1128521631?lang=en_US&edition=fundamental","pubTime":"2021-07-12 07:55","market":"hk","language":"zh","title":"Tengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.","url":"https://stock-news.laohu8.com/highlight/detail?id=1128521631","media":"老虎资讯综合","summary":"7月12日,腾盛博药-B发布公告,发售价厘定为每股发售股份22.25港元,全球发售所得款项净额预计约为23.34亿港元(假设超额配股权未获行使),预期股份将于2021年7月13日(星期二)上午九时正(","content":"<p>On July 12,<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>The announcement stated that the offer price was set at HK$22.25 per offer share, and the net proceeds from the global offering are expected to be approximately HK$2.334 billion (assuming the over-allotment option is not exercised). Trading in the shares on the Stock Exchange is expected to commence at 9:00 a.m. (Hong Kong time) on Tuesday, July 13, 2021.</p><p><b>The relevant data compiled by Tiger Information is as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6804fe5ca9085f6481244e4a826c03d7\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Allocation Results:</b></p><p>Group A has 500 shares per lot, with a 5% success rate per lot. Subscribing to 40 lots guarantees one lot.</p><p>Group B had 30,000 shares (600 lots) and was allocated 4,500 shares (9 lots).</p><p><img src=\"https://static.tigerbbs.com/6cc9c803bdb4af0ada0033deaba2cc37\" tg-width=\"726\" tg-height=\"769\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/8be19769443a8c996cbf0f219b3cd790\" tg-width=\"734\" tg-height=\"392\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/6f25a813ef2012066cd493f9512952f7\" tg-width=\"738\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p><p>If the over-allotment option is exercised in full, the company will receive additional net proceeds of approximately HK$357 million for the 16.737 million additional offer shares to be issued upon the exercise of the over-allotment option.</p><p>The Hong Kong Public Offering was significantly oversubscribed. A total of 246,500 valid applications were received for a total of 3.259 billion Hong Kong Offer Shares, which is approximately 292 times the total number of 11.158 million Hong Kong Offer Shares initially available for subscription under the Hong Kong Public Offering.</p><p>As the Hong Kong Public Offering was oversubscribed by more than 100 times, 44.632 million offer shares were reallocated from the international offering to the Hong Kong Public Offering. The final number of offer shares under the Hong Kong Public Offering has thus increased to 55.79 million offer shares, representing 50% of the total number of offer shares initially available for subscription under the Global Offering (before any over-allotment option is exercised).</p><p>The Offer Shares initially offered under the International Offering have been significantly oversubscribed, representing approximately 12 times the total number of Offer Shares initially available under the International Offering. Following the reallocation of Offer Shares from the International Offering to the Hong Kong Public Offering, the final number of Offer Shares under the International Offering will be 55.79 million, representing 50% of the total number of Offer Shares initially available for subscription under the Global Offering (before the exercise of any Over-allotment Option). The international offering was over-allocated by 16.737 million shares, with a total of 160 placees.</p><p>Based on the Offer Price of HK$22.25 per Offer Share, the Cornerstone Investors have subscribed for a total of 53,027,500 Offer Shares pursuant to the Cornerstone Investment Agreement, representing approximately 7.51% of the Company's issued share capital immediately following the completion of the Global Offering and 47.52% of the number of Offer Shares under the Global Offering, both assuming that the Over-allotment Option is not exercised.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTengsheng Biopharmaceutical-B has a 5% success rate in one lot; subscribing to 40 lots guarantees one lot.\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-12 07:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On July 12,<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>The announcement stated that the offer price was set at HK$22.25 per offer share, and the net proceeds from the global offering are expected to be approximately HK$2.334 billion (assuming the over-allotment option is not exercised). Trading in the shares on the Stock Exchange is expected to commence at 9:00 a.m. (Hong Kong time) on Tuesday, July 13, 2021.</p><p><b>The relevant data compiled by Tiger Information is as follows:</b></p><p><img src=\"https://static.tigerbbs.com/6804fe5ca9085f6481244e4a826c03d7\" tg-width=\"1059\" tg-height=\"824\" referrerpolicy=\"no-referrer\"></p><p><b>Allocation Results:</b></p><p>Group A has 500 shares per lot, with a 5% success rate per lot. Subscribing to 40 lots guarantees one lot.</p><p>Group B had 30,000 shares (600 lots) and was allocated 4,500 shares (9 lots).</p><p><img src=\"https://static.tigerbbs.com/6cc9c803bdb4af0ada0033deaba2cc37\" tg-width=\"726\" tg-height=\"769\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/8be19769443a8c996cbf0f219b3cd790\" tg-width=\"734\" tg-height=\"392\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/6f25a813ef2012066cd493f9512952f7\" tg-width=\"738\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p><p>If the over-allotment option is exercised in full, the company will receive additional net proceeds of approximately HK$357 million for the 16.737 million additional offer shares to be issued upon the exercise of the over-allotment option.</p><p>The Hong Kong Public Offering was significantly oversubscribed. A total of 246,500 valid applications were received for a total of 3.259 billion Hong Kong Offer Shares, which is approximately 292 times the total number of 11.158 million Hong Kong Offer Shares initially available for subscription under the Hong Kong Public Offering.</p><p>As the Hong Kong Public Offering was oversubscribed by more than 100 times, 44.632 million offer shares were reallocated from the international offering to the Hong Kong Public Offering. The final number of offer shares under the Hong Kong Public Offering has thus increased to 55.79 million offer shares, representing 50% of the total number of offer shares initially available for subscription under the Global Offering (before any over-allotment option is exercised).</p><p>The Offer Shares initially offered under the International Offering have been significantly oversubscribed, representing approximately 12 times the total number of Offer Shares initially available under the International Offering. Following the reallocation of Offer Shares from the International Offering to the Hong Kong Public Offering, the final number of Offer Shares under the International Offering will be 55.79 million, representing 50% of the total number of Offer Shares initially available for subscription under the Global Offering (before the exercise of any Over-allotment Option). The international offering was over-allocated by 16.737 million shares, with a total of 160 placees.</p><p>Based on the Offer Price of HK$22.25 per Offer Share, the Cornerstone Investors have subscribed for a total of 53,027,500 Offer Shares pursuant to the Cornerstone Investment Agreement, representing approximately 7.51% of the Company's issued share capital immediately following the completion of the Global Offering and 47.52% of the number of Offer Shares under the Global Offering, both assuming that the Over-allotment Option is not exercised.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","relate_stocks":{"02137":"腾盛博药-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128521631","content_text":"7月12日,腾盛博药-B发布公告,发售价厘定为每股发售股份22.25港元,全球发售所得款项净额预计约为23.34亿港元(假设超额配股权未获行使),预期股份将于2021年7月13日(星期二)上午九时正(香港时间)开始在联交所买卖。\n老虎资讯整理相关数据如下:\n\n分配结果:\n甲组每手500股,一手中签率5%,认购40手稳中一手。\n乙组头为3万股(600手),获配4500股(9手)。\n\n倘超额配股权获悉数行使,公司将就超额配股权获行使后拟发行的1673.7万股额外发售股份收取额外所得款项净额约3.57亿港元。\n香港公开发售获大量超额认购。合共接获24.65万份有效申请,认购合共32.59亿股香港发售股份,相当于香港公开发售项下初步可供认购香港发售股份总数1115.8万股的约292倍。\n由于香港公开发售的超额认购超过100倍,4463.2万股发售股份已由国际发售重新分配至香港公开发售。香港公开发售项下发售股份的最终数目由此增加至5579万股发售股份,相当于全球发售项下初步可供认购发售股份总数的50%(于任何超额配股权获行使前)。\n国际发售项下初步提呈发售的发售股份已获大幅超额认购,相当于国际发售项下初步可供认购发售股份总数的约12倍。于将发售股份由国际发售重新分配至香港公开发售后,国际发售项下发售股份最终数目为5579万股,相当于全球发售项下初步可供认购发售股份总数的50%(于任何超额配股权获行使前)。国际发售项下超额分配1673.7万股发售股份,并共有160名承配人。\n基于发售价每股发售股份22.25港元,根据基石投资协议,基石投资者已认购合共5302.75万股发售股份,相当于紧随全球发售完成后本公司已发行股本的约7.51%及全球发售项下发售股份数目的47.52%,两种情况均假设超额配股权未获行使。","news_type":1,"symbols_score_info":{"02137":0.9}},"isVote":1,"tweetType":1,"viewCount":5147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171283674,"gmtCreate":1626746246698,"gmtModify":1703764336165,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171283674","repostId":"2152955658","repostType":4,"isVote":1,"tweetType":1,"viewCount":4755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142818216,"gmtCreate":1626140518635,"gmtModify":1703754112950,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/142818216","repostId":"1199045893","repostType":4,"repost":{"id":"1199045893","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626139221,"share":"https://ttm.financial/m/news/1199045893?lang=en_US&edition=fundamental","pubTime":"2021-07-13 09:20","market":"hk","language":"zh","title":"Opening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.","url":"https://stock-news.laohu8.com/highlight/detail?id=1199045893","media":"老虎资讯综合","summary":"7月13日,恒生指数开盘上涨178.79点,涨幅0.65%,报27694.03点;国企指数开盘上涨49.98点,涨幅0.5%,报9995.71点;红筹指数开盘上涨18.1点,涨幅0.47%,报3867","content":"<p>On July 13, the Hang Seng Index opened up 178.79 points, or 0.65%, at 27,694.03. The state-owned enterprises index opened 49.98 points higher, or 0.5%, at 9995.71. The red-chip index opened 18.1 points higher, or 0.47%, at 3867.61.</p><p>The Hang Seng Tech Index rose 0.54%, with major tech stocks rebounding.<a href=\"https://laohu8.com/S/00700\">Tencent Holdings</a>、<a href=\"https://laohu8.com/S/BABA\">Alibaba</a>、<a href=\"https://laohu8.com/S/09888\">Baidu Group - SW</a>、<a href=\"https://laohu8.com/S/09618\">JD.com - SW</a>Both rose by more than 1%;</p><p>Hong Kong-listed mobile game stocks led the gains.<a href=\"https://laohu8.com/S/02660\">Zenyou Technology</a>Up 3.36%<a href=\"https://laohu8.com/S/09999\">NetEase-S</a>Up 2.13%<a href=\"https://laohu8.com/S/00302\">CMGE</a>Up 0.52%;</p><p>New Shares<a href=\"https://laohu8.com/S/06913\">South China Vocational Education</a>On its first day of trading, the stock price fell below its issue price, opening down 8.8% at HK$1.59 per share.</p><p>New Shares<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>On its first day of trading, the stock price fell below its issue price, opening nearly 4% lower at HK$22.25 per share.</p><p><a href=\"https://laohu8.com/S/01799\">Xinte Energy</a>The company opened 5.75% higher and expects a profit attributable to owners of no less than RMB 1.15 billion in the first half of the year;</p><p><a href=\"https://laohu8.com/S/09969\">Innovent Biologics-B</a>The stock opened more than 4% higher, reaching a new high. Bojian reached a licensing and cooperation agreement with Bojian for orlabrutinib.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpening: The Hang Seng Index rose 0.65%, while two newly listed stocks both fell below their issue price.\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time smaller\">2021-07-13 09:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>On July 13, the Hang Seng Index opened up 178.79 points, or 0.65%, at 27,694.03. The state-owned enterprises index opened 49.98 points higher, or 0.5%, at 9995.71. The red-chip index opened 18.1 points higher, or 0.47%, at 3867.61.</p><p>The Hang Seng Tech Index rose 0.54%, with major tech stocks rebounding.<a href=\"https://laohu8.com/S/00700\">Tencent Holdings</a>、<a href=\"https://laohu8.com/S/BABA\">Alibaba</a>、<a href=\"https://laohu8.com/S/09888\">Baidu Group - SW</a>、<a href=\"https://laohu8.com/S/09618\">JD.com - SW</a>Both rose by more than 1%;</p><p>Hong Kong-listed mobile game stocks led the gains.<a href=\"https://laohu8.com/S/02660\">Zenyou Technology</a>Up 3.36%<a href=\"https://laohu8.com/S/09999\">NetEase-S</a>Up 2.13%<a href=\"https://laohu8.com/S/00302\">CMGE</a>Up 0.52%;</p><p>New Shares<a href=\"https://laohu8.com/S/06913\">South China Vocational Education</a>On its first day of trading, the stock price fell below its issue price, opening down 8.8% at HK$1.59 per share.</p><p>New Shares<a href=\"https://laohu8.com/S/02137\">Tengsheng Biopharma-B</a>On its first day of trading, the stock price fell below its issue price, opening nearly 4% lower at HK$22.25 per share.</p><p><a href=\"https://laohu8.com/S/01799\">Xinte Energy</a>The company opened 5.75% higher and expects a profit attributable to owners of no less than RMB 1.15 billion in the first half of the year;</p><p><a href=\"https://laohu8.com/S/09969\">Innovent Biologics-B</a>The stock opened more than 4% higher, reaching a new high. Bojian reached a licensing and cooperation agreement with Bojian for orlabrutinib.</p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","relate_stocks":{"513600":"恒生指数ETF南方","02833":"恒指ETF","HSI":"恒生指数","HSCCI":"红筹指数","HSTECH":"恒生科技指数","HSCEI":"国企指数"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199045893","content_text":"7月13日,恒生指数开盘上涨178.79点,涨幅0.65%,报27694.03点;国企指数开盘上涨49.98点,涨幅0.5%,报9995.71点;红筹指数开盘上涨18.1点,涨幅0.47%,报3867.61点。\n恒生科技指数涨0.54%,大型科技股反弹,腾讯控股、阿里巴巴、百度集团-SW、京东集团-SW均涨逾1%;\n港股手游股涨幅居前,禅游科技涨3.36%,网易-S涨2.13%,中手游涨0.52%;\n新股华南职业教育上市首日破发,开跌8.8%,发行价为1.59港元/股;\n新股腾盛博药-B上市首日破发,开跌近4%,发行价22.25港元/股;\n新特能源高开5.75% 预期上半年拥有人应占利润不少于11.5亿元;\n诺诚健华-B高开超4%创新高 与渤健就奥布替尼达成许可及合作协议。","news_type":1,"symbols_score_info":{"513600":0.9,"MCHmain":0.9,"02833":0.9,"HSI":0.9,"MHImain":0.9,"HSCCI":0.9,"HHImain":0.9,"HSCEI":0.9,"HSImain":0.9,"HSTECH":0.9}},"isVote":1,"tweetType":1,"viewCount":4459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146119600,"gmtCreate":1626058265900,"gmtModify":1703752525155,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146119600","repostId":"2150309877","repostType":4,"isVote":1,"tweetType":1,"viewCount":4959,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146196580,"gmtCreate":1626057341740,"gmtModify":1703752503199,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Excited ","listText":"Excited ","text":"Excited","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/146196580","repostId":"2150583935","repostType":4,"isVote":1,"tweetType":1,"viewCount":5093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127853167,"gmtCreate":1624843997359,"gmtModify":1703845944961,"author":{"id":"3586549737202999","authorId":"3586549737202999","name":"Jasonteo","avatar":"https://static.tigerbbs.com/c65e51a6c7aa32f9d87734f24dea5af2","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586549737202999","authorIdStr":"3586549737202999"},"themes":[],"title":"","htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127853167","repostId":"2146007781","repostType":4,"isVote":1,"tweetType":1,"viewCount":4514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}